Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
UTAH MEDICAL PRODUCTS INC (UTMD)
|
Add to portfolio |
|
|
|
| Price: |
$87.20
| | Metrics |
| OS: |
3.63
|
M
| |
|
|
| Market cap: |
$316
|
M
| |
|
|
|
|
|
| |
|
|
|
|
|
| | | |
| | | | | |
| TTM Valuation | | | |
|
|
|
| |
|
|
|
|
|
| |
|
|
| EPS |
| |
|
|
|
BVPS
|
$33.55
| |
2.60
|
x P/B
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
| In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 |
| Revenues | 52.3 | 49.1 | 42.2 | 46.9 | 42.0 | 41.4 | 39.3 | 40.2 |
| Revenue growth | 6.6% | 16.3% | -10.1% | 11.7% | 1.4% | 5.4% | -2.1% | -2.7% |
| Cost of goods sold | 20.1 | 18.1 | 16.6 | 17.4 | 15.7 | 15.0 | 15.6 | 16.0 |
| Gross profit | 32.2 | 30.9 | 25.5 | 29.5 | 26.3 | 26.4 | 23.7 | 24.2 |
| Gross margin | 61.6% | 63.0% | 60.6% | 62.8% | 62.6% | 63.7% | 60.3% | 60.2% |
| Sales and marketing | 1.5 | 1.4 | 1.6 | 1.7 | 1.7 | 1.5 | 1.7 | 2.2 |
| Research and development | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.4 | 0.5 | 0.5 |
| General and administrative | 10.4 | 10.1 | 9.8 | 9.6 | 5.4 | 5.4 | 5.4 | 5.8 |
| EBITA | 26.2 | 25.5 | 20.2 | 23.8 | 20.9 | 21.1 | 18.4 | 18.2 |
| EBITA margin | 50.1% | 52.0% | 47.9% | 50.7% | 49.7% | 51.0% | 46.8% | 45.3% |
| Amortization of intangibles | 6.4 | 6.6 | 6.5 | 6.1 | 2.2 | 2.1 | 2.2 | 2.5 |
| EBIT | 19.8 | 18.9 | 13.7 | 17.6 | 18.7 | 19.0 | 16.2 | 15.7 |
| EBIT margin | 37.9% | 38.5% | 32.5% | 37.6% | 44.5% | 45.9% | 41.2% | 39.0% |
| Pre-tax income | 20.7 | 19.1 | 13.8 | 17.9 | 19.5 | 19.1 | 16.4 | 15.5 |
| Income taxes | 4.2 | 4.3 | 3.0 | 3.2 | 0.9 | 10.6 | 4.3 | 3.7 |
| Tax rate | 20.3% | 22.4% | 22.0% | 17.7% | 4.6% | 55.4% | 26.1% | 23.8% |
| Net income | 16.5 | 14.8 | 10.8 | 14.7 | 18.6 | 8.5 | 0.0 | 11.8 |
| Net margin | 31.5% | 30.1% | 25.6% | 31.4% | 44.2% | 20.5% | 0.0% | 29.5% |
| |
| Diluted EPS | $4.52 | $4.04 | $2.94 | $3.94 | $4.95 | $2.28 | $0.00 | $3.14 |
| Shares outstanding (diluted) | 3.6 | 3.7 | 3.7 | 3.7 | 3.7 | 3.7 | 0.0 | 3.8 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|